Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cellsBrent W. Sutherland, Sandra E. Dunn, Michaël Pollak et al.|Oncogene|2005Cited by 305
Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 studyErica L. Mayer, Michael Gnant, Amylou C. Dueck et al.|The Lancet Oncology|2021Cited by 255
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R. Diamond, Kathy D. Miller|Breast Cancer Research|2018Cited by 69
Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast CancerMilan Radovich, Kathy D. Miller|Clinical Cancer Research|2022Cited by 29
Change, Change, We've Got Change!Kathy D. Miller|Computers in libraries: Complete coverage of library information technology|1999Cited by 0